Member Login

Flora Hammond, MD

Speaker at 2015 NABIS Conference on Brain Injury

Session Title: Evidence for the Pharmacologic Treatment of Irritability and Aggression after Brain Injury
Objectives: 
1) To provide an overview of the possible pathobiology of aggression in non-brain injury populations to lay the ground work for treatment in brain injury.
2) To summarize the scientific literature for the pharmacologic management of irritability and aggression in brain injury.
3) To present the findings of recently completed clinical trials for the treatment of irritability and aggression after brain injury.
Summary: Theories for the pathobiology of aggression in non-brain injury populations are discussed to lay the ground work for the treatment of aggression in brain injury. Then, the scientific literature for the pharmacologic management of irritability and aggression in brain injury is reviewed. The studies that are the highest level of evidence are highlighted.  Lastly, the findings of recently completed clinical trials of amantadine for the treatment of irritability and aggression after traumatic brain injury are presented and discussed.

Current Company Affiliation:  Indiana University School of Medicine
Speaker Bio:  Flora Hammond, MD, FACRM: Dr. Hammond is a board certified in Physical Medicine and Rehabilitation. She is Professor and Chair of the Department of Physical Medicine and Rehabilitation at Indiana University School of Medicine; Chief of Medical Affairs and Brain Injury Medical Director at the Rehabilitation Hospital of Indiana; Medical Director at St. Vincent Acute Rehabilitation Unit; and Medical Director for the NeuroRestorative site in Indiana. She has been a Project Director of for the Traumatic Brain Injury Model System since 1998.  Her accomplishments in research, teaching, and administration have been acknowledged by receipt of the 2001 Association of Academic Physiatrists Young Academician Award and the 2011 Brain Injury Association of America William Caveness Award.

 

To read more about the meeting, click here.